DUBLIN, Oct. 20, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/x2cv6f/global) has announced the addition of the "Global Neuroprosthetics Market 2015-2019 - Industry research report" report to their offering.
The report forecasts the global neuroprosthetics market to grow at a CAGR of 7.08% over the period 2014-2019.
The report, Global Neuroprosthetics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global neuroprosthetics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Most neuroprosthetics manufacturers are US-based companies. These companies acquire overseas device manufacturers to expand their businesses and for tax exemptions. For instance, Medtronic acquired Covidien in January 2015 to reduce the cost of taxes generated on the former's revenue. Pfizer is expected to acquire UK-based AstraZeneca in part to gain entry into the UK. This deal can help Pfizer reduce its taxes by $1 billion annually.
According to the report, individuals with chronic pain, epilepsy, Parkinson's disease, and depression prefer first-line treatment options such as meditation, physiotherapy, and drugs. However, people with these diseases may develop resistance to drugs, resulting in the ineffectiveness of first-line treatment options. In these cases, people opt for neuroprosthetic devices as a second-line treatment option. These devices have many advantages over first-line treatment options.
Further, the report states that the high cost of neuroprosthetics coupled with reimbursement restrictions impedes the accessibility of these devices.
- Boston Scientific
- St. Jude Medical
Other prominent vendors
- Autonomic Technologies
- Mainstay Medical
- Oticon Medical
- Soterix Medical
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Reimbursement for neuroprosthetics
Part 06: Emerging technologies in neuroprosthetics
Part 07: Recent market approvals
Part 08: Market landscape
Part 09: Market segmentation by application
Part 10: Global cognitive devices market
Part 11: Global neuromodulation devices market
Part 12: Market segmentation by technology
Part 13: Geographical segmentation
Part 14: Market drivers
Part 15: Impact of drivers
Part 16: Market challenges
Part 17: Impact of drivers and challenges
Part 18: Market trends
Part 19: Vendor landscape
Part 20: Key vendor analysis
For more information visit http://www.researchandmarkets.com/research/x2cv6f/global
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets